Copy
hypertension.cochrane.org
View this email in your browser
Trusted evidence. Informed decisions. Better health.
Issue 16, Autumn 2021
Highlighted review:
Calcium channel blockers for hypertension
How do calcium channel blockers compare to other antihypertensive drugs for hypertension? Our updated systematic review looks at evidence from 23 RCTs with 153,849 participants with high blood pressure.

Read the review: https://bit.ly/3pcK1lC
The future of evidence synthesis in Cochrane

On September 9, 2021, Cochrane’s Editor in Chief, Karla Soares-Weiser, presented a reimagining of Cochrane’s model for synthesizing evidence to the Cochrane Community at the Join the Conversation webinars. 


Rethinking Cochrane’s model for producing evidence syntheses is a significant undertaking that needs the collective intellect and passion of our highly skilled and committed Cochrane community. There are different options for change that we could pursue; the new Future Cochrane website presents one potential model for our community to consider. Information gathered via this site, in the Community Engagement Workshops and collected as part of the Editorial Independence and Efficiency Project will inform a business case to be presented to the Governing Board by the end of December 2021.

Explore the different components of this programme here:
 https://bit.ly/3EIw0R5

Editorial Manager migration
All Cochrane review groups, including Cochrane Hypertension, are now moving their editorial processes from Archie to the online submission system Editorial Manager.

Learn more about Editorial Manager here:
https://training.cochrane.org/online-learning/em-training
Our latest reviews

As of November 2021, The Cochrane Library contains 81 reviews and 39 protocols under Cochrane Hypertension and 25 additional titles have been registered by the group for authors intending to undertake systematic reviews.

Latest protocols [P], reviews [R], updates [U]:

Calcium channel blockers versus other classes of drugs for hypertension [U]
Pharmacotherapy for hypertension-induced left ventricular hypertrophy [R]
Methods Speaker Series - Register now!
 UBC Therapeutics Initiative Methods Speaker Series events are free and feature expert speakers presenting a wide range of research methods topics. View recordings of past events or find future methods webinars.

Next presentation:

Systematic review searching: an overview of best practices & real world experiences
Speaker: Rebecca Rishar
Date: 24 November 2021
Register + info: 
https://bit.ly/3nxRSaU 
Webinar: Which medicines are essential in Canada?
Register for the 8th December UBC Therapeutics Initiative Best Evidence webinar, featuring Dr. Nav Persaud's presentation "Which medicines are essential in Canada?"

By the end of this session, participants should be able to:

  • Select a short list of medicines for use in clinical practice
  • Find resources about essential medicines
  • Explain the likely effects of providing people with free access to essential medicines
Registration and further details: https://ti.ubc.ca/EssentialMeds
Methods support web clinics for Cochrane authors & staff

Each month, Cochrane Review authors and Cochrane Review Group staff are invited to join a 60 minute web clinic hosted by Cochrane's Methods Support Unit, based within the Editorial and Methods Department, to discuss methodological questions during the production of Cochrane Protocols and Reviews. 


For more information and to register for upcoming clinics, please see: 
https://methods.cochrane.org/about/methods-support-unit/methods-support-unit-web-clinic-schedule

Setting priorities for Cochrane Hypertension reviews

Phase two of our HTN priority-setting project continues.  We've recently compliled the results of our survey asking patients, carers, clinicians, and other stakeholders to rank the top ten topics they feel are most important to be answered by Cochrane Hypertension systematic reviews. 
 

See the topics to which we are now mapping current and future review titles: 
https://hypertension.cochrane.org/htnpriorities

INGUIDE: guideline credentialing programme

The INGUIDE Program is a comprehensive, evidence-based, and up-to-date training program for guideline recommendation and development. It is the product of a partnership between GIN and world-renowned experts in guideline research, development, and implementation at McMaster University's Department of Health Research Methods, Evidence, and Impact. In addition, the program curriculum is developed by director of Cochrane Canada, Dr. Holger Schünemann, along with other active researchers from Cochrane Canada.
 

The program launched in September 2020 and is a professional certification program in guideline development and its mission is to improve the quality of practice guidelines globally, as well as reduce the amount of time and resources required to produce guidelines.

Website
Website
Twitter
Twitter
Email
Email

 






This email was sent to <<Email Address>>
why did I get this?    unsubscribe from this list    update subscription preferences
Cochrane Hypertension · 2176 Health Sciences Mall · Vancouver, BC V6T 1Z3 · Canada

Email Marketing Powered by Mailchimp